Skip to content

Return on equity at other companies

Artivion logo
ArtivionAORT
3.1%+1.8pp
AngioDynamics logo
AngioDynamicsANGO
-17.5%-2.2pp
AIR
AirSculpt Technologies, Inc.AIRS
-21.6%-78.3pp
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
-27.8%+0.2pp
AtriCure logo
AtriCureATRC
-6.1%-1.3pp
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-80.7%+3.1pp

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Calculated from Apyx Medical Corporation’s reported figures.

Based on trailing twelve months.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's return on equity?
Apyx Medical Corporation (APYX) reported return on equity of -77.8% in Q1 2026.
How has Apyx Medical Corporation's return on equity changed year-over-year?
Apyx Medical Corporation's return on equity increased by 40.5% year-over-year, from -130.7% to -77.8%.
What is the long-term trend for Apyx Medical Corporation's return on equity?
Over 5 years (2020 to 2025), Apyx Medical Corporation's return on equity has grown at a 34.4% compound annual growth rate (CAGR), from -17.6% to -77.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.